Kerala Ayurveda Faces Financial Challenges Amid Declining Profitability and High Debt Burden

Mar 05 2025 08:02 AM IST
share
Share Via
Kerala Ayurveda, a microcap in the Pharmaceuticals & Drugs sector, recently experienced a financial evaluation adjustment amid flat performance and an operating loss for the December 2024 quarter. The company faces challenges, including a high debt burden and declining operating profit over five years, raising concerns about its long-term viability.
Kerala Ayurveda, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation adjustment that reflects its current financial standing. The company reported flat financial performance for the quarter ending December 2024, with a notable operating loss. Over the past five years, Kerala Ayurveda has experienced a decline in operating profit, averaging an annual rate of -3.45%.

The company's financial metrics indicate a high debt burden, with a debt-to-equity ratio averaging 10.88 times, which raises concerns about its long-term fundamental strength. Additionally, the return on capital employed stands at a modest 5.75%, suggesting limited profitability relative to the total capital utilized.

In the latest quarter, the profit after tax was recorded at Rs -2.89 crore, reflecting a significant drop compared to the previous four-quarter average. The operating profit to interest ratio reached its lowest point at -2.77 times, further highlighting the challenges faced by the company.

Despite generating a return of 16.91% over the past year, Kerala Ayurveda's valuation appears expensive, with an enterprise value to capital employed ratio of 4.9. The technical trend remains sideways, indicating a lack of clear price momentum.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News